Fetal safety of loratadine use in the first trimester of pregnancy: A multicenter study

Background: Women in their childbearing years often require drug therapy for allergic conditions. Loratadine, a newer nonsedating antihistamine, is often used because of its preferred side effect profile. To date no published data exist on the safety of loratadine use in pregnancy. Objective: We sou...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of allergy and clinical immunology Vol. 111; no. 3; pp. 479 - 483
Main Authors:	Moretti, Myla E., Caprara, Daniela, Coutinho, Christopher J., Bar-Oz, Benjamin, Berkovitch, Mati, Addis, Antonio, Jovanovski, Elena, Schüler-Faccini, Lavínia, Koren, Gideon
Format:	Journal Article
Language:	English
Published:	New York, NY Mosby, Inc 01-03-2003 Elsevier Elsevier Limited
Subjects:	Abnormalities, Drug-Induced - epidemiology Adult Age allergy Anti-Allergic Agents - administration & dosage Anti-Allergic Agents - adverse effects Biological and medical sciences birth defect Birth weight Confidence intervals Control Groups Defects Dose-Response Relationship, Drug Drug Administration Schedule Drug dosages Drug toxicity and drugs side effects treatment Female Fetus - drug effects Hernias Humans Incidence Loratadine Loratadine - administration & dosage Loratadine - adverse effects Medical sciences Miscellaneous (drug allergy, mutagens, teratogens...) Patients Pharmacology. Drug treatments Pregnancy Pregnancy Trimester, First Safety Studies teratogens birth defect allergy teratogens pregnancy Loratadine TIS Human Immunopathology Allergy Antihistaminic Pregnancy Chemotherapy Treatment Female Antagonist Teratogen H1 Histamine receptor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!